CONNECT WITH US
Fintech

Fintech

Pine Labs, Paytm, MobiKwik Shares Slide Amid Reports Of UPI MDR Delay

Inc42 – Fintech logo

Published on

Add as a preferred source on Google
Pine Labs, Paytm, MobiKwik Shares Slide Amid Reports Of UPI MDR Delay

Shares of fintech companies Paytm, Pine Labs and MobiKwik came under pressure today following reports that the proposed merchant discount rate (MDR) on select UPI transactions could be deferred.

Paytm’s stock fell as much as 10% to an intraday low of ₹1,560.60 apiece on the BSE. As of 13:30 PM IST, the stock was trading 5.21% lower at ₹1,643 apiece, giving the company a market capitalisation of ₹1,05,416.1 Cr ($10.8 Bn).

Pine Labs was trading 4.3% lower at ₹169.90 apiece, with a market capitalisation of ₹19,619.18 Cr ($2 Bn).  

MobiKwik, meanwhile, was trading 5.7% lower at ₹241.25 apiece, with a market capitalisation of ₹1,899.7 Cr ($196.3 Mn).

The sell-off comes amid reports that the rollout of MDR on select UPI transactions may be deferred from October 15, to January 1, 2027.

As per a report by Business Standard, a proposal to defer the MDR rollout is under consideration, with a final decision expected in the coming days. The delay, if approved, would keep eligible merchant UPI payments free of MDR through the festive season.

The UPI and Services Steering Committee, headed by NPCI, met on Wednesday to discuss the proposed rollout among various other aspects of the framework.

The committee is also considering increasing the exemption threshold to businesses with an annual turnover of up to ₹40 Lakh. Under the earlier proposal, merchants receiving up to ₹1 Lakh a month through UPI QR codes directly into their bank accounts would be exempt from the fee.

Meanwhile, the RBI governor Sanjay Malhotra said on Wednesday that a “small fee” in the form of MDR is unlikely to have a major impact on UPI transaction volumes.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.